6533b839fe1ef96bd12a5b1b

RESEARCH PRODUCT

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

Richard F. SchlenkVerena I. GaidzikH-a HorstWalter FiedlerDavid NachbaurDoris KraemerGuido KobbeVeronica TeleanuDaniela WeberBernd HertensteinJürgen KrauterAlexander BurchardtHartmut DöhnerPeter BrossartMark RinghofferKatharina GötzeHelmut R. SalihPeter PaschkaHans-juergen SalwenderStephan KremersMichael HeuserMichael LübbertK DöhnerFelicitas TholM. WattadArnold GanserHeinz KirchenP FrechGerhard HeldGerald WulfElisabeth KollerThomas Fischer

subject

OncologyAdultMaleCancer Researchmedicine.medical_specialtyMyeloidAdolescentmedicine.medical_treatmentSalvage therapyHematopoietic stem cell transplantationOutcome (game theory)03 medical and health sciencesYoung Adult0302 clinical medicineText miningRecurrencehemic and lymphatic diseasesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansYoung adultLetter to the EditorAgedAged 80 and overSalvage Therapybusiness.industryHematopoietic Stem Cell TransplantationMyeloid leukemiaHematologyMiddle Agedmedicine.diseasePrognosisLeukemiaLeukemia Myeloid Acutemedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisFemalebusiness030215 immunology

description

Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

10.1038/leu.2017.22http://europepmc.org/articles/PMC5420792